María A. Jasnis

Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer

Gabriel L. Fiszman, María A. Jasnis · International Journal of Breast Cancer · 2011 · 119 citations · Full text

Medicine, Oncology, Pharmacology +17

IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response

Soraya Adris, S Klein, María A. Jasnis et al. · Gene Therapy · 1999 · 72 citations · Full text

Life Sciences, Immunology, Oncology +17

Arginine metabolic pathways involved in the modulation of tumor‐induced angiogenesis by macrophages

L Davel, María A. Jasnis, Eulalia de la Torre et al. · FEBS Letters · 2002 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids

Cristina E. Rodríguez, Sara Reidel, Elisa Bal de Kier Joffé et al. · PLoS ONE · 2015 · 40 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3

Gabriela Magenta, Ximena Borenstein, Romina Rolando et al. · BMC Cancer · 2008 · 36 citations · Full text

Medicine, Oncology, Pharmacology +11